Year: 2001
Type: article
Study design: Case Report
Abstract: This Brief Report describes a patient with the rare syndrome of tumor-induced osteomalacia, which is accompanied by phosphaturia and hypophosphatemia. Renal phosphate wasting, presumably caused by phosphatonins, was abolished by octreotide, a synthetic somatostatin analogue, before successful surgical removal of a benign hemangiopericytoma.
Source: New England Journal of Medicine
DOI: 10.1056/nejmoa010839
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2136483324
